PLUS1
3.41
0.08 (2.4%)
0.08 (2.4%)
Upgrade to Real-Time
Regular Market
Low
0.81
High
9.80
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Atossa Therapeutics Inc | ATOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.08 | 2.4% | 3.41 | 15:17:26 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.35 | 3.29 | 3.45 | 3.33 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.40 | 3.41 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,784 | 2,631,287 | $ 3.39 | $ 8,917,989 | - | 0.81 - 9.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:17:26 | 2 | $ 3.4029 | USD |
Period:
Draw Mode:
Atossa Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 431.79M | 126.62M | 126.57M | $ - | $ - | -1.97 | -2.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -164.58k | 0.40% |
Atossa Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.48 | 4.11 | 3.19 | 3.58 | 7,965,006 | -0.07 | -2.01% |
| 1 Month | 3.27 | 4.3101 | 3.17 | 3.63 | 7,044,741 | 0.14 | 4.28% |
| 3 Months | 7.28 | 9.80 | 2.75 | 5.33 | 15,106,623 | -3.87 | -53.16% |
| 6 Months | 2.90 | 9.80 | 1.48 | 4.55 | 14,602,501 | 0.51 | 17.59% |
| 1 Year | 2.2835 | 9.80 | 0.81 | 3.61 | 13,546,616 | 1.13 | 49.33% |
| 3 Years | 1.68 | 9.80 | 0.755 | 3.62 | 5,029,152 | 1.73 | 102.98% |
| 5 Years | 26.28 | 31.20 | 0.755 | 4.28 | 3,611,799 | -22.87 | -87.02% |
Atossa Therapeutics Description
| Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in the US. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use. |
